MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs

[1]  William N. Venables,et al.  Modern Applied Statistics with S , 2010 .

[2]  J. Minna,et al.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science? , 2010, Lung cancer.

[3]  R. Bast,et al.  The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade , 2010, Cancer Microenvironment.

[4]  M. O'Brien,et al.  Treatment options for small cell lung cancer – do we have more choice? , 2010, British Journal of Cancer.

[5]  E. Birney,et al.  A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.

[6]  H. Benjamin,et al.  Accurate Classification of Non–Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach , 2010, Clinical Cancer Research.

[7]  Yingdong Zhao,et al.  MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer , 2010, Clinical Cancer Research.

[8]  D. de Ruysscher.  Treatment of limited disease small cell lung cancer. , 2010, Frontiers of radiation therapy and oncology.

[9]  Zsolt Czimmerer,et al.  DIFFERENTIALLY EXPRESSED MicroRNAs IN SMALL CELL LUNG CANCER , 2009, Experimental lung research.

[10]  C. Croce.  Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.

[11]  Oliver Hofmann,et al.  miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. , 2009, Molecular cell.

[12]  Clay B Marsh,et al.  MicroRNAs in the Pathogenesis of Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  F. Wang,et al.  The property of methylated APC gene promotor and its influence on lung cancer cell line. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  W. Cho,et al.  Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. , 2009, European journal of cancer.

[15]  John D. Minna,et al.  miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1 , 2009, Molecular Cancer Research.

[16]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[17]  A. Schetter,et al.  MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers , 2009, Proceedings of the National Academy of Sciences.

[18]  Tao Yu,et al.  The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster , 2009, Journal of experimental & clinical cancer research : CR.

[19]  K. Okudela,et al.  Small Cell Lung Cancer: Significance of RB Alterations and TTF-1 Expression in its Carcinogenesis, Phenotype, and Biology , 2009, Endocrine pathology.

[20]  Gideon Rechavi,et al.  Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Packham,et al.  MicroRNAs: key players in carcinogenesis and novel therapeutic targets. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  P. Barbry,et al.  MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. , 2009, Current medicinal chemistry.

[23]  Fabrizio Galimberti,et al.  Uncovering Growth-Suppressive MicroRNAs in Lung Cancer , 2009, Clinical Cancer Research.

[24]  N. Lynam‐Lennon,et al.  The roles of microRNA in cancer and apoptosis , 2009, Biological reviews of the Cambridge Philosophical Society.

[25]  A. Burny,et al.  Evolution of microRNA expression during human bronchial squamous carcinogenesis , 2008, European Respiratory Journal.

[26]  Gerard J. Nuovo,et al.  Erratum: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 (Journal of Biological Chemistry (2018) 293 (33394–33405) DOI: 10.1074/jbc.M804788200) , 2008 .

[27]  Tasneem Motiwala,et al.  Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer , 2008, Journal of Biological Chemistry.

[28]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[29]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[30]  Reuven Agami,et al.  Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. , 2008, Cancer research.

[31]  C. Croce,et al.  MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer , 2008, Oncogene.

[32]  Reuven Agami,et al.  miR-148 targets human DNMT3b protein coding region. , 2008, RNA.

[33]  George A Calin,et al.  MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.

[34]  Phillip A Sharp,et al.  Suppression of non-small cell lung tumor development by the let-7 microRNA family , 2008, Proceedings of the National Academy of Sciences.

[35]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[36]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[37]  Fang Zhou,et al.  Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.

[38]  J. M. Thomson,et al.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.

[39]  C. Morrison,et al.  MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.

[40]  F. Slack,et al.  The let-7 microRNA represses cell proliferation pathways in human cells. , 2007, Cancer research.

[41]  S. Janes,et al.  Lung cancer and lung stem cells: strange bedfellows? , 2007, American journal of respiratory and critical care medicine.

[42]  H. Hsu,et al.  Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. , 2007, Lung cancer.

[43]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[44]  Stefano Volinia,et al.  MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  Quynh-Thu Le,et al.  Non-small cell lung cancer: Clinical practice guidelines in oncology , 2006 .

[46]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[47]  J. Minna,et al.  Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. , 2006, Cancer research.

[48]  I. Wistuba,et al.  Lung cancer preneoplasia. , 2006, Annual review of pathology.

[49]  Hisao Asamura,et al.  Neuroendocrine neoplasms of the lung: a prognostic spectrum. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  Y. Yatabe,et al.  A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.

[51]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[52]  D. Jackman,et al.  Small-cell lung cancer , 2005, The Lancet.

[53]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[54]  Elisabeth Brambilla,et al.  The 2004 World Health Organization classification of lung tumors. , 2005, Seminars in roentgenology.

[55]  J. Herman,et al.  Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. , 2005, The Journal of thoracic and cardiovascular surgery.

[56]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[57]  C. Perou,et al.  A custom microarray platform for analysis of microRNA gene expression , 2004, Nature Methods.

[58]  Walter Krämer,et al.  Review of Modern applied statistics with S, 4th ed. by W.N. Venables and B.D. Ripley. Springer-Verlag 2002 , 2003 .

[59]  Stephen B. Baylin,et al.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.

[60]  W. Travis,et al.  The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. , 2003, Human pathology.

[61]  G. Kalemkerian,et al.  Small cell lung cancer , 2010, Seminars in Respiratory and Critical Care Medicine.

[62]  Brian D. Ripley,et al.  Modern applied statistics with S, 4th Edition , 2002, Statistics and computing.

[63]  J. Schiller,et al.  Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer , 2001, Oncology.

[64]  W. Benedict,et al.  Differential retinoblastoma and p16INK4A protein expression in neuroendocrine tumors of the lung , 2000, Cancer.

[65]  D. Groggel.  Practical Nonparametric Statistics , 1972, Technometrics.

[66]  E. Brambilla,et al.  Alterations of expression of Rb, p16INK4A and cyclin D1 in non‐small cell lung carcinoma and their clinical significance , 1999, The Journal of pathology.

[67]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Schuermann,et al.  Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins , 1998, Oncogene.

[69]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[70]  J. Minna,et al.  NCI‐navy medical oncology branch cell line data base , 1996, Journal of cellular biochemistry. Supplement.

[71]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[72]  S. Piantadosi,et al.  Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience. , 1994, Chest.

[73]  S. O’Lear,et al.  The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. , 1994, Cancer research.

[74]  J. Minna,et al.  Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. , 1992, Cancer research.

[75]  J. Minna,et al.  Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. , 1985, Cancer research.

[76]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.